aTTom (adjuvant Tamoxifen-To offer more?): Randomized trial of 10 versus 5 years of adjuvant tamoxifen among 6,934 women with estrogen receptor-positive (ER+) or ER untested breast cancer-Preliminary results
Gray RG., Rea DW., Handley K., Marshall A., Pritchard MG., Perry P., Earl HM., Poole CJ., Salman A., Lee M.